Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Hepatocellular 7Leukemia, Myeloid, Acute 5Recurrence 4Hepatitis C, Chronic 4Hepatitis C 4Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Respiratory Tract Infections 2Lymphoma, Mantle-Cell 2Infections 2Head and Neck Neoplasms 2Breast Neoplasms 2Wilms Tumor 1Testicular Neoplasms 1Teratoma, Testicular 1Teratoma 1Seminoma 1Respiratory Syncytial Virus Infections 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Neuroblastoma 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Multiple Myeloma 1Malignant Solid Tumor 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1

Interventions

Cyclophosphamide 87fludarabine 74Tacrolimus 45fludarabine phosphate 44Mycophenolic Acid 42Whole-Body Irradiation 41Busulfan 35Melphalan 31Antilymphocyte Serum 24thymoglobulin 22Methotrexate 22Rituximab 21venetoclax 20Standard of Care 20Sirolimus 20Azacitidine 20Thiotepa 19Stem Cell Transplantation 18Granulocyte Colony-Stimulating Factor 18Practice Guidelines as Topic 16Cytarabine 16Nivolumab 15Filgrastim 15Dexamethasone 14Cyclosporine 13Bortezomib 13Mesna 12Peripheral Blood Stem Cell Transplantation 11trametinib 10Specimen Handling 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hematologic Neoplasms × Ribavirin × Clear all
NCT00500578 2012-08-01

Intermittent Use of Aerosolized Ribavirin for Treatment of RSV

M.D. Anderson Cancer Center

Phase 4 Completed
51 enrolled 8 charts
Other hematologic neoplasm

Respiratory Tract Infections, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡